Compugen
Biotechnology
Healthcare
CGEN
89.82 M shares
NASDAQ US
traded
03 Apr 2025
listed
no
open
1.38
52 week high
2.57
high
1.53
52 week low
1.41
previous Close
1.46
P/E ratio
market cap
142 M
div yield
0
net incoming
1.28 M
160.10 %
net profit margin
7.45 %
39.00 %
operating incoming
4.50 M
231.77 %
net change in cash
0.00 %
cash on hand
7.22 M
-39.24 %
cost of revenue
3.60 M
132.02 %
top